ENOB   $0.7  2.86% Market Closed

Enochian Biosciences Inc
Total Cash 2.95M
totalCashPerShare 0.051
EBITDA -20.46M
Total Debt 7.54M
quickRatio 0.25
currentRatio 0.334
Total Revenue
debtToEquity 11.398
Revenue/Share
ROA -0.099379994
ROE -0.93876
grossProfits
freeCashflow -6.26M
operatingCashflow -12.56M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 45.39M
forwardPE
floatShares 27.81M
sharesOutstanding 63.70M
sharesShort 1.44M
sharesShortPriorMonth 1.46M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.60%
heldPercentInstitutions 0.06%
Short Ratio help_outline 2.40%
shortPercentOfFloat 0.06%
impliedSharesOutstanding
bookValue 1.14
Price To Book help_outline 0.61
earningsQuarterlyGrowth
netIncomeToCommon -106.72M
trailingEps -2.07%
forwardEps
enterpriseToEbitda -2.22
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 67
lastUpdated Aug. 18, 2023, 6:32 p.m.